Jolivet-Reynaud C, Dalbon P, Viola F, Yvon S, Paranhos-Baccala G, Piga N, Bridon L, Trabaud M A, Battail N, Sibai G, Jolivet M
Département des Immunoessais, bioMérieux, Marcy l'Etoile, France.
J Med Virol. 1998 Dec;56(4):300-9. doi: 10.1002/(sici)1096-9071(199812)56:4<300::aid-jmv3>3.0.co;2-8.
Monoclonal antibodies (MAbs) were generated by immunizing mice with a truncated recombinant protein corresponding to the immunodominant region (residues 1-120) of hepatitis C virus (HCV) nucleocapsid protein. The specific recognition by either human sera or mouse monoclonal antibodies of overlapping peptides spanning the core region 1-120 as well as the comparison with epitopes described earlier allowed the fine mapping of HCV core. Within the region 1-120, the major antigenic domain could be restricted to the first 45 amino acids. Indeed, the peptide S42G (residues 2-45) allowed the detection of an anti-HCV core response by all anticore-positive human sera examined. According to their epitope localization, three groups of mouse MABs could be evidenced that were directed against different regions of core. Group II MAbs recognized a strictly linear epitope (QDVKF, residues 20-24), whereas group I MABs were directed against a conformational epitope mainly located at the amino acid residues (QIVGG, 29-33). The epitope of group III MABs was also conformational (PRGRRQPI, residues 58-65). These three epitopes appeared close but different from the three major human epitopes RKTKRNTN, VYLLPR, and GRTWAQPGYPWPLY (residues 7-17, 34-39, and 73-86, respectively). Group II MAB 7G12A8 and group I MAB 19D9D6 were used in a sandwich ELISA for the capture and the detection, respectively, of viral core antigen in sera of patients with chronic HCV infection. After treatment of sera with triton x 100 in acidic conditions, amounts of viral antigen as low as 20 pg/ml of sera could be detected.
用对应于丙型肝炎病毒(HCV)核衣壳蛋白免疫显性区域(第1 - 120位氨基酸残基)的截短重组蛋白免疫小鼠,产生单克隆抗体(MAb)。人血清或小鼠单克隆抗体对跨越核心区域1 - 120的重叠肽的特异性识别以及与先前描述的表位的比较,使得能够对HCV核心进行精细定位。在1 - 120区域内,主要抗原结构域可能局限于前45个氨基酸。实际上,肽S42G(第2 - 45位氨基酸残基)能被所有检测的抗核心阳性人血清检测到抗HCV核心反应。根据其表位定位,可证实有三组小鼠单克隆抗体针对核心的不同区域。第二组单克隆抗体识别一个严格线性表位(QDVKF,第20 - 24位氨基酸残基),而第一组单克隆抗体针对一个主要位于氨基酸残基(QIVGG,第29 - 33位)的构象表位。第三组单克隆抗体的表位也是构象性的(PRGRRQPI,第58 - 65位氨基酸残基)。这三个表位看似相近,但与三个人类主要表位RKTKRNTN、VYLLPR和GRTWAQPGYPWPLY(分别为第7 - 17位、34 - 39位和73 - 86位氨基酸残基)不同。第二组单克隆抗体7G12A8和第一组单克隆抗体19D9D6分别用于夹心ELISA中捕获和检测慢性HCV感染患者血清中的病毒核心抗原。在酸性条件下用曲拉通x 100处理血清后,血清中低至20 pg/ml的病毒抗原量也能被检测到。